Merck’s Keytruda, on the heels of a first-line kidney cancer win, targets earlier, post-surgery use

  • by
Merck’s Keytruda, on the heels of a first-line kidney cancer win, targets earlier, post-surgery use
aliu
Thu, 04/08/2021 – 09:37